These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29292076)
1. Local Regulation of Thrombin Activity by Factor Xa in Peripheral Nerve Schwann Cells. Gera O; Bushi D; Ben Shimon M; Artan-Furman A; Harnof S; Maggio N; Dori A; Chapman J; Shavit-Stein E Neuroscience; 2018 Feb; 371():445-454. PubMed ID: 29292076 [TBL] [Abstract][Full Text] [Related]
2. Thrombin and protein C pathway in peripheral nerve Schwann cells. Gera O; Shavit-Stein E; Bushi D; Harnof S; Shimon MB; Weiss R; Golderman V; Dori A; Maggio N; Finegold K; Chapman J Neuroscience; 2016 Dec; 339():587-598. PubMed ID: 27771530 [TBL] [Abstract][Full Text] [Related]
3. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin. Wong PC; Jiang X Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316 [TBL] [Abstract][Full Text] [Related]
4. Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values. Siddiqui F; Tafur A; Ramacciotti LS; Jeske W; Hoppensteadt D; Ramacciotti E; Iqbal O; Fareed J Clin Appl Thromb Hemost; 2019; 25():1076029619863493. PubMed ID: 31298056 [TBL] [Abstract][Full Text] [Related]
5. Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors. Schreuder M; Jourdi G; Veizaj D; Poole DA; Cheung KL; Poenou G; Verhoef D; Thomassen S; Janssen LFH; Stepanian A; Hackeng TM; Gaussem P; Reitsma PH; Geerke DP; Siguret V; Bos MHA J Thromb Haemost; 2024 Aug; 22(8):2211-2226. PubMed ID: 38729577 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Neuronal Activity on Glial Thrombin Generation. Gera O; Shavit-Stein E; Chapman J J Mol Neurosci; 2019 Apr; 67(4):589-594. PubMed ID: 30684238 [TBL] [Abstract][Full Text] [Related]
7. Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke. Bushi D; Chapman J; Wohl A; Stein ES; Feingold E; Tanne D J Neurosci Res; 2018 Aug; 96(8):1406-1411. PubMed ID: 29761540 [TBL] [Abstract][Full Text] [Related]
8. Induction of parathyroid hormone-related peptide following peripheral nerve injury: role as a modulator of Schwann cell phenotype. Macica CM; Liang G; Lankford KL; Broadus AE Glia; 2006 Apr; 53(6):637-48. PubMed ID: 16470617 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of direct factor IIa and factor Xa inhibitors in protein C-deficient plasma detected using thrombin generation and viscoelastometry assays. Aungraheeta R; FitzGibbon L; Reilly-Stitt C; Mumford AD Int J Lab Hematol; 2020 Apr; 42(2):126-133. PubMed ID: 31756037 [TBL] [Abstract][Full Text] [Related]
10. The mRNA of transferrin is expressed in Schwann cells during their maturation and after nerve injury. Salis C; Setton CP; Soto EF; Pasquini JM Exp Neurol; 2007 Sep; 207(1):85-94. PubMed ID: 17628542 [TBL] [Abstract][Full Text] [Related]
11. Local production of serum amyloid a is implicated in the induction of macrophage chemoattractants in Schwann cells during wallerian degeneration of peripheral nerves. Jang SY; Shin YK; Lee HY; Park JY; Suh DJ; Kim JK; Bae YS; Park HT Glia; 2012 Oct; 60(10):1619-28. PubMed ID: 22777957 [TBL] [Abstract][Full Text] [Related]
13. Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era. Rühl H; Reda S; Müller J; Oldenburg J; Pötzsch B Thromb Haemost; 2018 Feb; 118(2):381-387. PubMed ID: 29378360 [TBL] [Abstract][Full Text] [Related]
14. Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban. Jourdi G; Siguret V; Martin AC; Golmard JL; Godier A; Samama CM; Gaussem P; Gouin-Thibault I; Le Bonniec B Thromb Haemost; 2015 Jul; 114(1):78-86. PubMed ID: 25761505 [TBL] [Abstract][Full Text] [Related]
15. Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor. Rico MC; Rough JJ; Manns JM; Del Carpio-Cano F; Safadi FF; Kunapuli SP; DeLa Cadena RA Thromb Res; 2012 Jun; 129(6):801-6. PubMed ID: 21889790 [TBL] [Abstract][Full Text] [Related]
16. Preparation and blood compatibility of polyethersulfone dialysis membrane modified by apixaban as coagulation factor Xa inhibitor. Fu X; Lei T; Xiao Y; Tang C Biomater Adv; 2022 Aug; 139():213012. PubMed ID: 35882156 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors. Yang J; Su G; Ren Y; Chen Y Eur J Med Chem; 2015 Aug; 101():41-51. PubMed ID: 26114810 [TBL] [Abstract][Full Text] [Related]
18. Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. Brummel-Ziedins KE; Orfeo T; Gissel M; Mann KG; Rosendaal FR PLoS One; 2012; 7(1):e29178. PubMed ID: 22247769 [TBL] [Abstract][Full Text] [Related]
19. Utilizing Plasma Composition Data to Help Determine Procoagulant Dynamics in Patients with Thermal Injury: A Computational Assessment. Bravo MC; Tejiram S; McLawhorn MM; Moffatt LT; Orfeo T; Jett-Tilton M; Pusateri AE; Shupp JW; Brummel-Ziedins KE Mil Med; 2019 Mar; 184(Suppl 1):392-399. PubMed ID: 30901410 [TBL] [Abstract][Full Text] [Related]
20. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis. Norledge BV; Petrovan RJ; Ruf W; Olson AJ Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]